Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (Ab191606)
GRB1, PIK3R1, Phosphatidylinositol 3-kinase regulatory subunit alpha, PI3-kinase regulatory subunit alpha, PI3K regulatory subunit alpha, PtdIns-3-kinase regulatory subunit alpha, Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha, PI3-kinase subunit p85-alpha, PtdIns-3-kinase regulatory subunit p85-alpha
详细信息
背景信息
What is this antibody validated in? Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (ab191606) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Immunoprecipitation (IP), Immunocytochemistry/immunofluorescence (ICC/IF) in African green monkey, Human, Mouse, Rat samples. What is the molecular weight of PI 3 Kinase p85 alpha? Anti-PI 3 Kinase p85 alpha [EPR18702] (ab191606) specifically detects a band for PI 3 Kinase p85 alpha (UniProt: Q63787) at a molecular weight of 84kDa. Trusted by the scientific community Anti-PI 3 Kinase p85 alpha [EPR18702] (ab191606) was first used in a scientific publication in 2016 and has been cited over 220 times in peer-reviewed journals. Specificity confirmed The specificity of Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (ab191606) has been confirmed by Western blot testing in PIK3R1 Knockout HAP1 cells. Other related products We have a range of other formats of antibody clone [EPR18702] also available for your convenience: ab191606, Carrier free - ab223792, APC - ab225369, PE - ab225370, Alexa Fluor® 488 - ab225371 Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies. Trial sizes available! Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 20µl. Discover our selection of trial-size antibodies.
文献引用 (389)
Targeting the SOX9/TIMP1 Axis with iRGD-Conjugated Nanoplatform Enhances Dendritic Cell Function and Photodynamic Immunotherapy in Gastric Cancer.
利用 iRGD 偶联纳米平台靶向 SOX9/TIMP1 轴可增强树突状细胞功能和光动力免疫疗法在胃癌中的疗效。
Discovery and identification of semaphorin 4D as a bioindicator of high fracture incidence in type 2 diabetic mice with glucose control.
发现并鉴定出信号素 4D 作为血糖控制良好的 2 型糖尿病小鼠骨折发生率高的生物标志物。
Targeting FN1 to overcome gemcitabine resistance in gallbladder cancer: Mechanistic insights and an iRGD-modified PEG-PLGA nanoparticle delivery strategy.
靶向 FN1 以克服胆囊癌吉西他滨耐药性:机制见解和 iRGD 修饰的 PEG-PLGA 纳米颗粒递送策略。
IL-4/Nanohydroxyapatite Codelivery in a Dual-Bionic Scaffold: Design and Immunomodulatory Endogenous Osteogenesis Mechanism.
IL-4/纳米羟基磷灰石在双仿生支架中的共递送:设计和免疫调节内源性成骨机制。
INHBA, regulated by C/EBPβ, induces M2 macrophage polarization to promote tumor metastasis and growth via activating the PI3K/AKT pathway in gastric cancer.
INHBA 受 C/EBPβ 调控,诱导 M2 巨噬细胞极化,通过激活胃癌中的 PI3K/AKT 通路促进肿瘤转移和生长。
Lactylation-related gene signature as a prognostic biomarker for neuroblastoma: insights into tumor progression and immune modulation.
乳酸相关基因特征作为神经母细胞瘤的预后生物标志物:对肿瘤进展和免疫调节的见解。
TRPS1 confers paclitaxel resistance in TNBC through dual activation of the PDE4D-cAMP-AKT pathway and microtubule destabilization.
TRPS1 通过 PDE4D-cAMP-AKT 通路的双重激活和微管不稳定化,赋予 TNBC 紫杉醇耐药性。
Synergistic anti-hepatoma effect of triptolide and quercetin via co-inhibition and interaction with Janus kinase and mammalian target of rapamycin signal pathway.
雷公藤内酯醇和槲皮素通过与 Janus 激酶和哺乳动物雷帕霉素靶蛋白信号通路的共同抑制和相互作用,发挥协同抗肝癌作用。
FGFR2 is a Candidate Immune-Associated Marker of Diabetic Foot Ulcer That Promotes Keratinocyte Function by Activating the PI3K/Akt and MAPK Pathways.
FGFR2 是糖尿病足溃疡的候选免疫相关标志物,它通过激活 PI3K/Akt 和 MAPK 通路促进角质形成细胞功能。
Insulin signaling pathway related m(6)A methylated biomarker for type 2 diabetes and the potential modulation mechanism.
胰岛素信号通路相关m(6)A甲基化生物标志物与2型糖尿病及其潜在调节机制。
- 1
- 2
- 3
- 4
- 5
- 6
- 39